BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$4.01 +0.07 (+1.78%)
As of: Oct 2, 2026 · 12:25 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Short-term Investments (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Short-term Investments of $171.65 million for Q2 2026, down 14.0% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Oncology Therapeutics posted Short-term Investments of $51.77 million, down 58.5% from FY2024.

  • By year, Short-term Investments came in at $124.78 million in FY2024.
  • Five-year quarterly Short-term Investments spans a low of $51.77 million in Q4 2025 and a high of $199.62 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $199.62 million (Q1 2026), $51.77 million (Q4 2025) and $59.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BridgeBio Oncology Therapeutics 328.47 Mn -1.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.65 Mn
Mar 31, 2026 199.62 Mn
Dec 31, 2025 51.77 Mn
Sep 30, 2025 59.54 Mn
Dec 31, 2024 124.78 Mn
API Access

BridgeBio Oncology Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=BBOT&period=max&api_key=YOUR_API_KEY